Sun Pharma, Cipla And More — Nirmal Bang's Top Stock Picks In Pharma Pack; Q1 Results Preview

Nirmal Bang expects Ajanta Pharma, Dr. Reddy's, JB Chemicals, Eris, Sun Pharma, and Lupin to outperform the IPM.

Nirmal Bang Institutional Research

14 Jul 2025, 07:30 AM IST i

<div class="paragraphs"><p>Pharma companies' margins are expected to improve YoY on the back of a better product mix, price hike benefits in branded markets, and normalizing cost inflation. (Photo source: Haberdoedas/ Unsplash)</p></div>

Pharma companies' margins are expected to improve YoY on the back of a better product mix, price hike benefits in branded markets, and normalizing cost inflation. (Photo source: Haberdoedas/ Unsplash)

Among the large caps, all coverage companies under Nirmal Bang are expected to a report decent set of numbers. In terms of revenue, Dr. Reddy’s (due to acquisition), Sun Pharma, Mankind Pharma (due to acquisition), and Ajanta Pharma are expected to report >10% YoY growth among the Large Caps, while Eris Life/JB Chemicals (due to acquisitions), Gland Pharma (on a low base), and Natco Pharma are expected to report double-digit YoY reve...